ストックスクリーナーアプリを入手
21.70
2.12%
0.45
アフターアワーズ：
21.77
0.07
+0.32%
前日終値:
$21.25
開ける：
$21.04
24時間の取引高:
229.22K
Relative Volume:
3.14
時価総額：
$237.51M
収益：
$56.54M
当期純損益:
$-30.70M
株価収益率:
-55.64
EPS:
-0.39
ネットキャッシュフロー:
$-31.05M
1週間 パフォーマンス:
-9.58%
1か月 パフォーマンス:
-4.87%
6か月 パフォーマンス:
+66.79%
1年 パフォーマンス:
+52.39%
1日の値動き範囲:
$20.76
$22.00
1週間の範囲:
$19.87
$24.39
52週間の値動き範囲:
$10.00
$28.42
Cidara Therapeutics Inc Stock (CDTX) Company Profile
名前
Cidara Therapeutics Inc
セクター
電話
858-752-6170
住所
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
CDTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
21.70 | 237.51M | 56.54M | -30.70M | -31.05M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-11-08 | 開始されました | Guggenheim | Buy |
| 2024-08-14 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | 再開されました | H.C. Wainwright | Buy |
| 2021-09-22 | アップグレード | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | 開始されました | Aegis Capital | Buy |
| 2019-09-04 | アップグレード | Wedbush | Neutral → Outperform |
| 2018-07-26 | 開始されました | Citigroup | Buy |
| 2017-04-21 | 開始されました | Raymond James | Strong Buy |
| 2017-04-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-12 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-04-11 | 再開されました | Wedbush | Outperform |
| 2017-02-22 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-02-22 | アップグレード | WBB Securities | Sell → Hold |
| 2016-12-21 | 再開されました | Leerink Partners | Outperform |
| 2016-12-19 | 開始されました | H.C. Wainwright | Buy |
| 2016-09-23 | ダウングレード | WBB Securities | Hold → Sell |
| 2015-10-09 | アップグレード | WBB Securities | Sell → Hold |
| 2015-05-11 | 開始されました | Jefferies | Buy |
| 2015-05-11 | 開始されました | Leerink Partners | Outperform |
| 2015-05-11 | 開始されました | Needham | Buy |
| 2015-05-11 | 開始されました | Wedbush | Outperform |
| 2015-04-23 | 開始されました | WBB Securities | Sell |
すべてを表示
Cidara Therapeutics Inc (CDTX) 最新ニュース
Contrasting Cidara Therapeutics (NASDAQ:CDTX) and Kodiak Sciences (NASDAQ:KOD) - Defense World
Here’s Why Cidara Therapeutics, Inc. (CDTX) Is Skyrocketing - MSN
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Short Interest Update - MarketBeat
Why These 24 Stocks Are Skyrocketing - Insider Monkey
Geode Capital Management LLC Buys 9,771 Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World
(CDTX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Cidara Therapeutics (NASDAQ:CDTX) Shares Cross Above 50 Day Moving AverageTime to Sell? - MarketBeat
Cidara Therapeutics announces board changes, CMO separation - Investing.com
Cidara Therapeutics Announces Leadership Changes and Appointments - MSN
Cidara Therapeutics, Inc. Announces Management Changes - Marketscreener.com
Aspergillosis Market Expected to rise, 2034 | Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, I - The Globe and Mail
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives $32.20 Average PT from Analysts - Defense World
Cidara Therapeutics stock soars to 52-week high of $24.99 By Investing.com - Investing.com Nigeria
Cidara Therapeutics stock soars to 52-week high of $24.99 - Investing.com
(CDTX) Proactive Strategies - Stock Traders Daily
Analysts Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) PT at $32.20 - MarketBeat
Influenza A Infections Market Overview: Size, Share, and Future - openPR
Cidara Therapeutics files to sell 7.04M shares of common stocks by selling shareholders - MSN
Long Term Trading Analysis for (CDTX) - Stock Traders Daily
Cidara Therapeutics (CDTX) Just Flashed Golden Cross Signal: Do You Buy? - MSN
Cidara Therapeutics stock soars to 52-week high of $24.4 - Investing.com
Cidara Therapeutics (NASDAQ:CDTX) versus Ginkgo Bioworks (NYSE:DNA) Financial Survey - Defense World
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Sees Large Increase in Short Interest - MarketBeat
Cidara Therapeutics (NASDAQ:CDTX) Coverage Initiated at Royal Bank of Canada - Defense World
RBC Capital Initiates Coverage of Cidara Therapeutics (CDTX) with Outperform Recommendation - MSN
Cidara Therapeutics (NASDAQ:CDTX) Now Covered by Analysts at Royal Bank of Canada - MarketBeat
Cidara achieves full enrolment in influenza prevention trial - Yahoo Finance
RA Capital Management L.P. Takes $7.56 Million Position in Cidara Therapeutics, Inc. (NASDAQ:CDTX) - MarketBeat
Cidara Therapeutics Completes Enrollment of Phase 2b - GlobeNewswire
Cidara Achieves Major Milestone: 5,000 Patients Enrolled in Game-Changing Universal Flu Prevention Trial - StockTitan
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Finance Watch: PIPEs Still Key Even As FOPO Fundraising Climbs - Citeline News & Insights
(CDTX) Trading Report - Stock Traders Daily
RA CAPITAL MANAGEMENT, L.P. Increases Stake in Cidara Therapeuti - GuruFocus.com
ATB’s €54M series A among largest ever in Belgium - BioCentury
Cidara Therapeutics announces $105 million private placement By Investing.com - Investing.com South Africa
Cidara Therapeutics announces $105 million private placement - Investing.com India
Cidara: Potential To Change Flu Prophylaxis Landscape With CD388 - Seeking Alpha
Cidara to raise up to $105 million in private placement - The Pharma Letter
Cidara Therapeutics shares surge on $105M equity private placement - MSN
Cidara Therapeutics Shares Surge 26% on $105 Mln Private Placement - MarketWatch
Cidara Therapeutics Announces $105 Million Private Placement - GlobeNewswire
Cidara Therapeutics Secures $105M Private Placement Led by Venrock Healthcare | CDTX Stock News - StockTitan
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference - GlobeNewswire
Cidara Therapeutics CEO to Present at Evercore HealthCONx Conference | CDTX Stock News - StockTitan
(CDTX) Technical Data - Stock Traders Daily
HC Wainwright Has Positive Outlook of CDTX FY2024 Earnings - MarketBeat
Cidara Therapeutics (NASDAQ:CDTX) Given Buy Rating at HC Wainwright - MarketBeat
Analysts Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) PT at $29.67 - MarketBeat
Cidara Therapeutics Inc (CDTX) 財務データ
収益
当期純利益
現金流量
EPS
Cidara Therapeutics Inc (CDTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Tari Leslie | CHIEF SCIENTIFIC OFFICER |
Sep 11 '24 |
Sale |
11.64 |
909 |
10,580 |
17,788 |
| Stein Jeffrey | President & CEO |
Jun 07 '24 |
Buy |
13.21 |
8,000 |
105,680 |
24,580 |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER |
Mar 11 '24 |
Sale |
0.67 |
21,029 |
14,085 |
258,681 |
| Sandison Taylor | Chief Medical Officer |
Mar 11 '24 |
Sale |
0.67 |
20,662 |
13,839 |
347,095 |
| Ward Shane | COO & CLO |
Mar 11 '24 |
Sale |
0.67 |
20,473 |
13,713 |
198,770 |
| Shah Preetam | CFO & CBO |
Mar 11 '24 |
Sale |
0.67 |
18,931 |
12,680 |
227,210 |
0.65%
4.62%
大文字化:
|
ボリューム (24 時間):